Lori Miller1, Neetha Morar2, Saidi Kapiga1,3, Gita Ramjee4, Richard Hayes1. 1. London School of Hygiene and Tropical Medicine, London, United Kingdom. 2. HIV Prevention Research Unit, Medical Research Council, Durban, South Africa. 3. Mwanza Intervention Trials Unit, Mwanza, Tanzania; and. 4. Aurum Institute, South Africa.
Abstract
BACKGROUND: Low adherence has contributed to disappointing results for trials testing vaginal microbicides for HIV prevention. This study engaged former gel trial participants to understand the reasons behind low adherence and seek suggestions on how to improve products and adherence to microbicides. This analysis examines the impact of participant perceptions of male partners on participant adherence and suggestions on how to address those issues. METHODS: Eight focus group discussion workshops were conducted with 46 former microbicide trial participants in South Africa and Tanzania. Participants provided feedback on why women join trials, barriers to using gels and reporting adherence accurately, and how adherence and adherence reporting can be improved. RESULTS: Participants reported that male partners can affect women's ability to use gels. For some, the lubricating effects caused relationship conflicts due to suspicion of male partners about infidelity. Needing to provide sex to partners on demand was a barrier to gel use. Participants suggested a gel formulation which was thicker and less noticeable, and explicit male partner engagement to enhance understanding of the purpose of the gels. CONCLUSIONS: The imbalance of power in intimate relationships affects the ability of women to use microbicides as directed. To improve adherence to HIV prevention methods within trials and for successful rollout of proven HIV prevention methods in populations, it is important that the complicated dynamics of sex and relationships be taken into greater consideration and that women receive targeted support to navigate product use and communication within the context of these gender dynamics.
BACKGROUND: Low adherence has contributed to disappointing results for trials testing vaginal microbicides for HIV prevention. This study engaged former gel trial participants to understand the reasons behind low adherence and seek suggestions on how to improve products and adherence to microbicides. This analysis examines the impact of participant perceptions of male partners on participant adherence and suggestions on how to address those issues. METHODS: Eight focus group discussion workshops were conducted with 46 former microbicide trial participants in South Africa and Tanzania. Participants provided feedback on why women join trials, barriers to using gels and reporting adherence accurately, and how adherence and adherence reporting can be improved. RESULTS: Participants reported that male partners can affect women's ability to use gels. For some, the lubricating effects caused relationship conflicts due to suspicion of male partners about infidelity. Needing to provide sex to partners on demand was a barrier to gel use. Participants suggested a gel formulation which was thicker and less noticeable, and explicit male partner engagement to enhance understanding of the purpose of the gels. CONCLUSIONS: The imbalance of power in intimate relationships affects the ability of women to use microbicides as directed. To improve adherence to HIV prevention methods within trials and for successful rollout of proven HIV prevention methods in populations, it is important that the complicated dynamics of sex and relationships be taken into greater consideration and that women receive targeted support to navigate product use and communication within the context of these gender dynamics.
Authors: K M Devries; J Y T Mak; C García-Moreno; M Petzold; J C Child; G Falder; S Lim; L J Bacchus; R E Engell; L Rosenfeld; C Pallitto; T Vos; N Abrahams; C H Watts Journal: Science Date: 2013-06-20 Impact factor: 47.728
Authors: Catherine M Montgomery; Mitzy Gafos; Shelley Lees; Neetha S Morar; Oliver Mweemba; Agnes Ssali; Jonathan Stadler; Robert Pool Journal: Cult Health Sex Date: 2010-08
Authors: Andrea R Wallace; Aaron Teitelbaum; Livia Wan; Maria Gloria Mulima; Laura Guichard; Stephanie Skoler; Stephanie Skiler; Hlengiwe Vilakazi; Fridda S Mapula; Jasmine Rossier; Sumen N Govender; Pekka Lahteenmaki; Robin A Maguire; David M Phillips Journal: Contraception Date: 2007-05-11 Impact factor: 3.375
Authors: Elizabeth T Montgomery; Sarah T Roberts; Annalene Nel; Mariette Malherbe; Kristine Torjesen; Katherine Bunge; Devika Singh; Jared M Baeten; Jeanne Marrazzo; Z Mike Chirenje; Samuel Kabwigu; Richard Beigi; Sharon A Riddler; Zakir Gaffour; Krishnaveni Reddy; Leila E Mansoor; Gonasagrie Nair; Kusbashni Woeber; Jayajothi Moodley; Nitesha Jeenarain; Samantha Siva; Logashvari Naidoo; Vaneshree Govender; Thesla Palanee-Phillips Journal: AIDS Date: 2019-11-15 Impact factor: 4.177
Authors: Sarah T Roberts; Jessica Haberer; Connie Celum; Nelly Mugo; Norma C Ware; Craig R Cohen; Jordan W Tappero; James Kiarie; Allan Ronald; Andrew Mujugira; Elioda Tumwesigye; Edwin Were; Elizabeth Irungu; Jared M Baeten Journal: J Acquir Immune Defic Syndr Date: 2016-11-01 Impact factor: 3.731
Authors: J Hanass-Hancock; S Hoffman; S Bergam; A D Harrison; N Benghu; S Khumalo; N Tesfay; T Exner; L Miller; C Dolezal Journal: AIDS Behav Date: 2022-02-26